STTCOMP WNX FA LONG
WELLNEX LIFE LIMITED
ASX: WNX
Share Price: 3.2c
SOI: 1,118,690,888
Market Cap: ~$40m
Cash on hand: $591k (as per last quarterly, does not include inventory)
- Achieved trading profit in February
- Record $2m+ in orders for Wellnex products in April
- Pearl Funds Management commiting $3m @ 2.8c, a 33% premium to today's share price of 2.1c
- PainAway has delivered significantly increased revenue + margins, aligned with its pre acquisition targets
- Attractive level to invest @ given the current lowly market cap after being beaten down post re-listing/acquisition
- LSE listing plans
Wellnex Life Limited is a pioneering Australian enterprise dedicated to serving the consumer health and wellness sector through its brand and distribution services
Highlighted by its headline products through its PainAway acquisition (acquired last year), PainAway is an established brand since 1999 and has grown to become the #2 provider of topical pain relief products in Australia
PainAway generated $12.4m revenue FY22'
Sales Channels
Key Pharmacy Wholesalers & Retailers include
- Chemist Warehouse
- Priceline Pharmacy
- Sigma
- Simbion
- Amcal
- Terry White
Key Supermarkets & Customers
- Woolworths
- Coles
- Aldi
With plans to list on the London Stock Exchange recently outlined in an announcement on April 23rd ("Wellnex to dual list on the London Stock Exchange"), a listing on the LSE will offer a foundation for expanding the companies reach both at home and abroad, let alone the various partnerships and synergies that may evolve organically from such listing. This milestone coincides with Wellnex's imminent venture into new international markets with its diverse range of brands and products
Key Points from the desk note listed below:
- Gross profit projections for FY24' and beyond have gross margin %'s hovering at and above ~29%
- Sales tipped to grow to over $49m for the FY25' period, and then $78m for the FY26'
- Despite the delays in both the PainAway transaction + the regulatory bottleneck of ticking off its 8 OTC applications, the company achieved an operational profit for the February period, demonstrating the strength of the business and the benefit of having multiple revenue streams
Link to an updated desk note: https://2581150.fs1.hubspotusercontent-na1.net/hubfs/2581150/WNX%20Research%20Update%20May%202024-1.pdf
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 03 Jun
STTCOMP WNX FA LONGWELLNEX LIFE LIMITEDASX: WNXShare Price:...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online